# Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses

> **NCT05848453** · PHASE1 · COMPLETED · sponsor: **Bacoba AG** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BAP5191

## Key facts

- **NCT ID:** NCT05848453
- **Lead sponsor:** Bacoba AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-28
- **Primary completion:** 2024-03-07
- **Final completion:** 2024-03-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-07-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05848453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05848453, "Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05848453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*